C07D 243/38
[b, e]- or [b, f]-condensed with six-membered rings
C07D243/38 ([b, e]- or [b, f]-condensed with six-membered rings) appears on 93 US grants and 93 published applications in this corpus.
Search patents in C07D- Granted patents
- 93
- Published applications
- 93
- Assignees
- 72
- Inventors
- 338
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 5 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 13 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 1 | 1 |
| 2003 | 1 | 3 |
| 2004 | 0 | 1 |
| 2005 | 3 | 6 |
| 2006 | 2 | 9 |
| 2007 | 6 | 7 |
| 2008 | 4 | 9 |
| 2009 | 1 | 7 |
| 2010 | 2 | 5 |
| 2011 | 0 | 2 |
| 2012 | 3 | 3 |
| 2013 | 3 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 3 |
| 2018 | 1 | 5 |
| 2019 | 3 | 0 |
| 2020 | 1 | 6 |
| 2021 | 2 | 5 |
| 2022 | 1 | 2 |
| 2023 | 4 | 6 |
| 2024 | 1 | 2 |
| 2025 | 4 | 4 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Salts of neuroceuticals and uses thereof25 Aug 2026US 12,714,711 B2SyneuRx International (Taiwan) Corp.
- Methods of synthesizing farnesyl dibenzodiazepinones14 Apr 2026US 12,600,703 B2AMO Pharma Ltd.
- c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same7 Oct 2025US 12,435,047 B2Pontifica Universidad Catoclica de Chile
- HECT E3 ligase inhibitors and uses thereof2 Sep 2025US 12,403,144 B2Ieo - Istituto Europeo Di Oncologia S.R.L.
- Modulators of orphan nuclear receptors for NASH and other metabolic disorders3 Jun 2025US 12,318,393 B2
- Clozapine Immunoassay13 Aug 2026US 2026/0235589 A1Saladax Biomedical Inc.
- C-abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same6 Nov 2025US 2025/0340521 A1Pontificia Universidad Catolica De Chile
- Compound, preparation and use thereof in rubber blends and vehicle tires, as an anti-aging agent, antioxidant, antioxidant and/or coloring agent7 Aug 2025US 2025/0250241 A1Continental Reifen Deutschland GmbH
- Compositions and methods for treatment of inflammatory diseases26 Jun 2025US 2025/0206714 A1Invea Therapeutics, Inc.
- Imaging method for designer receptor, antagonist or agonist, pharmaceutical, and companion diagnostic agent27 Feb 2025US 2025/0064992 A1National Institutes for Quantum and Radiological Science and Technology
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Pharmaceutical formulations for parenteral use93US 4,983,586 AUniversity of Florida · 1991
- Redox systems for brain-targeted drug delivery58US 5,017,566 AUniversity of Florida · 1991
- Tricyclic benzazepine vasopressin antagonists50US 5,512,563 AAmerican Cyanamid Company · 1996
- Tricyclic benzazepine vasopressin antagonists46US 5,849,735 AAmerican Cyanamid Company · 1998